Page 376 - Binder2

2. Clinics: From Procedure Factories to Monitoring
Hubs

Biologic delivery has become a significant revenue driver
for clinics and hospitals—not because the drugs themselves
are profitable, but because their administration is
billable.

Every infusion or injection brings with it a cascade of
reimbursable services:

• IV setup and supervision
• Facility fees
• Monitoring
• Lab work
• Post-procedure observation

In many systems, biologics are a financial backbone—not
just a therapeutic intervention.

But oral biologics strip away the need for:

• Injections
• Monitoring rooms
• Procedural staff
• Refrigerated storage

The visit becomes a check-in, not a transaction.

This has two major effects:

1. Revenue compression.
Health systems that rely on biologics as a procedural
revenue stream may resist adoption of edible alternatives—
especially when margins disappear.

374